-
1
-
-
51649091930
-
Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis
-
Creighton CJ, Casa A, Lazard Z, et al. Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis. J Clin Oncol 2008; 26: 4078-85.
-
(2008)
J Clin Oncol
, vol.26
, pp. 4078-4085
-
-
Creighton, C.J.1
Casa, A.2
Lazard, Z.3
-
2
-
-
0028958031
-
Insulin-like growth factors and their binding proteins: Biological actions
-
Jones JI, Clemmons DR,. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995; 16: 3-34.
-
(1995)
Endocr Rev
, vol.16
, pp. 3-34
-
-
Jones, J.I.1
Clemmons, D.R.2
-
3
-
-
0242594016
-
The IGF-1 receptor in cancer biology
-
Baserga R, Peruzzi F, Reiss K,. The IGF-1 receptor in cancer biology. Int J Canc 2003; 107: 873-7.
-
(2003)
Int J Canc
, vol.107
, pp. 873-877
-
-
Baserga, R.1
Peruzzi, F.2
Reiss, K.3
-
4
-
-
0032499440
-
Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
-
Hankinson SE, Willett WC, Colditz GA, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998; 351: 1393-6.
-
(1998)
Lancet
, vol.351
, pp. 1393-1396
-
-
Hankinson, S.E.1
Willett, W.C.2
Colditz, G.A.3
-
5
-
-
34247534611
-
Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer
-
Baglietto L, English DR, Hopper JL, et al. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer. Canc Epidemiol Biomark Prev 2007; 16: 763-8.
-
(2007)
Canc Epidemiol Biomark Prev
, vol.16
, pp. 763-768
-
-
Baglietto, L.1
English, D.R.2
Hopper, J.L.3
-
6
-
-
77953536809
-
Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: Pooled individual data analysis of 17 prospective studies
-
Key TJ, Appleby PN, Reeves GK, et al. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 2010; 11: 530-42.
-
(2010)
Lancet Oncol
, vol.11
, pp. 530-542
-
-
Key, T.J.1
Appleby, P.N.2
Reeves, G.K.3
-
7
-
-
0037869234
-
Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer
-
Keinan-Boker L, Bueno De Mesquita HB, Kaaks R, et al. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer. Int J Canc 2003; 106: 90-5.
-
(2003)
Int J Canc
, vol.106
, pp. 90-95
-
-
Keinan-Boker, L.1
Bueno De Mesquita, H.B.2
Kaaks, R.3
-
8
-
-
33745104067
-
IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC)
-
Rinaldi S, Peeters PH, Berrino F, et al. IGF-I, IGFBP-3 and breast cancer risk in women: the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Canc 2006; 13: 593-605.
-
(2006)
Endocr Relat Canc
, vol.13
, pp. 593-605
-
-
Rinaldi, S.1
Peeters, P.H.2
Berrino, F.3
-
9
-
-
16844374390
-
Circulating levels of Insulin-like Growth Factors, their binding proteins, and breast cancer risk
-
Schernhammer ES, Holly JM, Pollak MN, et al. Circulating levels of Insulin-like Growth Factors, their binding proteins, and breast cancer risk. Canc Epidemiol Biomark Prev 2005; 14: 699-704.
-
(2005)
Canc Epidemiol Biomark Prev
, vol.14
, pp. 699-704
-
-
Schernhammer, E.S.1
Holly, J.M.2
Pollak, M.N.3
-
10
-
-
1942436958
-
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: Systematic review and meta-regression analysis
-
Renehan AG, Zwahlen M, Minder C, et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004; 363: 1346-53.
-
(2004)
Lancet
, vol.363
, pp. 1346-1353
-
-
Renehan, A.G.1
Zwahlen, M.2
Minder, C.3
-
11
-
-
3242884950
-
IGF-I and breast cancer: A meta-analysis
-
Shi R, Yu H, McLarty J, et al. IGF-I and breast cancer: a meta-analysis. Int J Canc 2004; 111: 418-23.
-
(2004)
Int J Canc
, vol.111
, pp. 418-423
-
-
Shi, R.1
Yu, H.2
McLarty, J.3
-
12
-
-
3142726250
-
Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: A meta-analysis of literature
-
Sugumar A, Liu YC, Xia Q, et al. Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a meta-analysis of literature. Int J Canc 2004; 111: 293-7.
-
(2004)
Int J Canc
, vol.111
, pp. 293-297
-
-
Sugumar, A.1
Liu, Y.C.2
Xia, Q.3
-
13
-
-
0036912055
-
Insulin-like growth factor i (IGF-I), IGF-binding proteins, and breast cancer
-
Krajcik RA, Borofsky ND, Massardo S, et al. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Canc Epidemiol Biomark Prev 2002; 11: 1566-73.
-
(2002)
Canc Epidemiol Biomark Prev
, vol.11
, pp. 1566-1573
-
-
Krajcik, R.A.1
Borofsky, N.D.2
Massardo, S.3
-
14
-
-
0035945656
-
Estrogen and the risk of breast cancer
-
Clemons M, Goss P,. Estrogen and the risk of breast cancer. New Eng J Med 2001; 344: 276-85.
-
(2001)
New Eng J Med
, vol.344
, pp. 276-285
-
-
Clemons, M.1
Goss, P.2
-
15
-
-
1642419529
-
Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe
-
Stahlberg C, Pedersen AT, Lynge E, et al. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe. Int J Canc 2004; 109: 721-7.
-
(2004)
Int J Canc
, vol.109
, pp. 721-727
-
-
Stahlberg, C.1
Pedersen, A.T.2
Lynge, E.3
-
16
-
-
84877875905
-
Menarche, menopause, and breast cancer risk: Individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies
-
Collaborative Group on Hormonal Factors in Breast Cancer.
-
Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 2012; 13: 1141-51.
-
(2012)
Lancet Oncol
, vol.13
, pp. 1141-1151
-
-
-
17
-
-
80053912279
-
Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: A nested case-control study
-
James RE, Lukanova A, Dossus L, et al. Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study. Canc Prev Res (Phil) 2011; 4: 1626-35.
-
(2011)
Canc Prev Res (Phil)
, vol.4
, pp. 1626-1635
-
-
James, R.E.1
Lukanova, A.2
Dossus, L.3
-
18
-
-
29144464971
-
Postmenopausal serum androgens, oestrogens and breast cancer risk: The European prospective investigation into cancer and nutrition
-
Kaaks R, Rinaldi S, Key TJ, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Canc 2005; 12: 1071-82.
-
(2005)
Endocr Relat Canc
, vol.12
, pp. 1071-1082
-
-
Kaaks, R.1
Rinaldi, S.2
Key, T.J.3
-
19
-
-
0030803940
-
A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey
-
Thomas HV, Key TJ, Allen DS, et al. A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey. Br J Canc 1997; 76: 401-5.
-
(1997)
Br J Canc
, vol.76
, pp. 401-405
-
-
Thomas, H.V.1
Key, T.J.2
Allen, D.S.3
-
20
-
-
14944373265
-
The role of endogenous hormones in the etiology and prevention of breast cancer: The Epidemiological Evidence
-
Muti P,. The role of endogenous hormones in the etiology and prevention of breast cancer: the Epidemiological Evidence. Ann N Y Acad Sci 2004; 1028: 273-82.
-
(2004)
Ann N y Acad Sci
, vol.1028
, pp. 273-282
-
-
Muti, P.1
-
21
-
-
0033842834
-
Crosstalk between the insulin-like growth factors and estrogens in breast cancer
-
Yee D, Lee AV,. Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J Mammary Gland Biol Neoplasia 2000; 5: 107-15.
-
(2000)
J Mammary Gland Biol Neoplasia
, vol.5
, pp. 107-115
-
-
Yee, D.1
Lee, A.V.2
-
22
-
-
84857915302
-
Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth
-
Casa A, Potter A, Malik S, et al. Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth. Breast Canc Res Treat 2012; 132: 61-73.
-
(2012)
Breast Canc Res Treat
, vol.132
, pp. 61-73
-
-
Casa, A.1
Potter, A.2
Malik, S.3
-
23
-
-
79960009788
-
Insulin-like growth factor-1 and 17beta-estradiol down-regulate prostate apoptosis response-4 expression in MCF-7 breast cancer cells
-
Casolari DA, Pereira MC, de Bessa Garcia SA, et al. Insulin-like growth factor-1 and 17beta-estradiol down-regulate prostate apoptosis response-4 expression in MCF-7 breast cancer cells. Int J Mol Med 2011; 28: 337-42.
-
(2011)
Int J Mol Med
, vol.28
, pp. 337-342
-
-
Casolari, D.A.1
Pereira, M.C.2
De Bessa Garcia, S.A.3
-
24
-
-
33846846385
-
Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: Involvement of transcription factor Sp1
-
Maor S, Mayer D, Yarden RI, et al. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1. J Endocrinol 2006; 191: 605-12.
-
(2006)
J Endocrinol
, vol.191
, pp. 605-612
-
-
Maor, S.1
Mayer, D.2
Yarden, R.I.3
-
25
-
-
84884725294
-
A comparison of hormonal profiles between breast cancer and benign breast disease: A case-control study
-
Lagiou P, Samoli E, Lagiou A, et al. A comparison of hormonal profiles between breast cancer and benign breast disease: a case-control study. Ann Oncol 2013; 24: 2527-33.
-
(2013)
Ann Oncol
, vol.24
, pp. 2527-2533
-
-
Lagiou, P.1
Samoli, E.2
Lagiou, A.3
-
26
-
-
1542725074
-
Diet and cancer - The European Prospective Investigation into Cancer and Nutrition
-
Bingham S, Riboli E,. Diet and cancer-the European Prospective Investigation into Cancer and Nutrition. Nat Rev Canc 2004; 4: 206-15.
-
(2004)
Nat Rev Canc
, vol.4
, pp. 206-215
-
-
Bingham, S.1
Riboli, E.2
-
27
-
-
0345700787
-
European Prospective Investigation into Cancer and Nutrition (EPIC): Study populations and data collection
-
Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002; 5: 1113-24.
-
(2002)
Public Health Nutr
, vol.5
, pp. 1113-1124
-
-
Riboli, E.1
Hunt, K.J.2
Slimani, N.3
-
29
-
-
0032786679
-
Follow-up procedures in EPIC-Germany - Data quality aspects
-
Bergmann MM, Bussas U, Boeing H,. Follow-up procedures in EPIC-Germany-data quality aspects. Ann Nutr Metab 1999; 43: 225-34.
-
(1999)
Ann Nutr Metab
, vol.43
, pp. 225-234
-
-
Bergmann, M.M.1
Bussas, U.2
Boeing, H.3
-
30
-
-
20544477209
-
Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC)
-
Kaaks R, Berrino F, Key T, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Canc Inst 2005; 97: 755-65.
-
(2005)
J Natl Canc Inst
, vol.97
, pp. 755-765
-
-
Kaaks, R.1
Berrino, F.2
Key, T.3
-
31
-
-
0036800654
-
Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations
-
Rinaldi S, Geay A, Dechaud H, et al. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Canc Epidemiol Biomark Prev 2002; 11: 1065-71.
-
(2002)
Canc Epidemiol Biomark Prev
, vol.11
, pp. 1065-1071
-
-
Rinaldi, S.1
Geay, A.2
Dechaud, H.3
-
32
-
-
0020963636
-
Tests for interaction in epidemiologic studies: A review and a study of power
-
Greenland S,. Tests for interaction in epidemiologic studies: a review and a study of power. Stat Med 1983; 2: 243-51.
-
(1983)
Stat Med
, vol.2
, pp. 243-251
-
-
Greenland, S.1
-
33
-
-
84896397455
-
-
3rd edn. Philadelphia, PA: Lippincott, Williams and Wilkins
-
Rothman KJ, Greenland S, Lash TL,. Modern epidemiology. 3rd edn. Philadelphia, PA: Lippincott, Williams and Wilkins, 2008. 279 p, 425 p.
-
(2008)
Modern Epidemiology
, vol.279
, pp. 425
-
-
Rothman, K.J.1
Greenland, S.2
Lash, T.L.3
-
34
-
-
0038237118
-
Progesterone receptors A and B differentially affect the growth of estrogen-dependent human breast tumor xenografts
-
Sartorius CA, Shen T, Horwitz KB,. Progesterone receptors A and B differentially affect the growth of estrogen-dependent human breast tumor xenografts. Breast Canc Res Treat 2003; 79: 287-99.
-
(2003)
Breast Canc Res Treat
, vol.79
, pp. 287-299
-
-
Sartorius, C.A.1
Shen, T.2
Horwitz, K.B.3
-
35
-
-
0023879109
-
Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines
-
Read LD, Snider CE, Miller JS, et al. Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines. Mol Endocrinol 1988; 2: 263-71.
-
(1988)
Mol Endocrinol
, vol.2
, pp. 263-271
-
-
Read, L.D.1
Snider, C.E.2
Miller, J.S.3
-
36
-
-
84882558986
-
Estrogen receptor negative/progesterone positive breast cancer is not a reproducible subtype
-
Hefti MM, Hu R, Knoblauch NW, et al. Estrogen receptor negative/progesterone positive breast cancer is not a reproducible subtype. Breast Canc Res 2013; 15: R68.
-
(2013)
Breast Canc Res
, vol.15
-
-
Hefti, M.M.1
Hu, R.2
Knoblauch, N.W.3
-
37
-
-
38349084668
-
Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist
-
author reply 336-8.
-
De Maeyer L, Van Limbergen E, De Nys K, et al. Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist J Clin Oncol 2008; 26: 335-6. author reply 336-8.
-
(2008)
J Clin Oncol
, vol.26
, pp. 335-336
-
-
De Maeyer, L.1
Van Limbergen, E.2
De Nys, K.3
-
38
-
-
0036299562
-
Oestrogen/insulin-like growth factor-I receptor interaction in early breast cancer: Clinical implications
-
Stoll BA,. Oestrogen/insulin-like growth factor-I receptor interaction in early breast cancer: clinical implications. Ann Oncol 2002; 13: 191-6.
-
(2002)
Ann Oncol
, vol.13
, pp. 191-196
-
-
Stoll, B.A.1
-
39
-
-
0030670432
-
The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue
-
Happerfield LC, Miles DW, Barnes DM, et al. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue. J Pathol 1997; 183: 412-7.
-
(1997)
J Pathol
, vol.183
, pp. 412-417
-
-
Happerfield, L.C.1
Miles, D.W.2
Barnes, D.M.3
-
40
-
-
0033305004
-
Enhancement of insulin-like growth factor signaling in human breast cancer: Estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo
-
Lee AV, Jackson JG, Gooch JL, et al. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol Endocrinol 1999; 13: 787-96.
-
(1999)
Mol Endocrinol
, vol.13
, pp. 787-796
-
-
Lee, A.V.1
Jackson, J.G.2
Gooch, J.L.3
-
41
-
-
0026738320
-
Type 1 IGF receptor in human breast diseases
-
Peyrat JP, Bonneterre J,. Type 1 IGF receptor in human breast diseases. Breast Canc Res Treat 1992; 22: 59-67.
-
(1992)
Breast Canc Res Treat
, vol.22
, pp. 59-67
-
-
Peyrat, J.P.1
Bonneterre, J.2
-
42
-
-
0023779434
-
Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors
-
Peyrat JP, Bonneterre J, Beuscart R, et al. Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors. Canc Res 1988; 48: 6429-33.
-
(1988)
Canc Res
, vol.48
, pp. 6429-6433
-
-
Peyrat, J.P.1
Bonneterre, J.2
Beuscart, R.3
-
43
-
-
8344278838
-
Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women
-
Gronbaek H, Flyvbjerg A, Mellemkjaer L, et al. Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women. Canc Epidemiol Biomark Prev 2004; 13: 1759-64.
-
(2004)
Canc Epidemiol Biomark Prev
, vol.13
, pp. 1759-1764
-
-
Gronbaek, H.1
Flyvbjerg, A.2
Mellemkjaer, L.3
-
44
-
-
31844450034
-
Premenopausal levels of circulating insulin-like growth factor i and the risk of postmenopausal breast cancer
-
Rollison DE, Newschaffer CJ, Tao Y, et al. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer. Int J Canc 2006; 118: 1279-84.
-
(2006)
Int J Canc
, vol.118
, pp. 1279-1284
-
-
Rollison, D.E.1
Newschaffer, C.J.2
Tao, Y.3
-
45
-
-
33745069283
-
Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in the Nurses Health Study II
-
Schernhammer ES, Holly JM, Hunter DJ, et al. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II. Endocr Relat Canc 2006; 13: 583-92.
-
(2006)
Endocr Relat Canc
, vol.13
, pp. 583-592
-
-
Schernhammer, E.S.1
Holly, J.M.2
Hunter, D.J.3
-
46
-
-
0034748233
-
A cross-sectional study of IGF-I determinants in women
-
Lukanova A, Toniolo P, Akhmedkhanov A, et al. A cross-sectional study of IGF-I determinants in women. Eur J Canc Prev 2001; 10: 443-52.
-
(2001)
Eur J Canc Prev
, vol.10
, pp. 443-452
-
-
Lukanova, A.1
Toniolo, P.2
Akhmedkhanov, A.3
-
47
-
-
0348012945
-
Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer
-
Lukanova A, Zeleniuch-Jacquotte A, Lundin E, et al. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int J Canc 2004; 108: 262-8.
-
(2004)
Int J Canc
, vol.108
, pp. 262-268
-
-
Lukanova, A.1
Zeleniuch-Jacquotte, A.2
Lundin, E.3
-
48
-
-
33644516398
-
Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period
-
Missmer SA, Spiegelman D, Bertone-Johnson ER, et al. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Canc Epidemiol Biomark Prev 2006; 15: 972-8.
-
(2006)
Canc Epidemiol Biomark Prev
, vol.15
, pp. 972-978
-
-
Missmer, S.A.1
Spiegelman, D.2
Bertone-Johnson, E.R.3
-
49
-
-
0034605463
-
Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women
-
Kaaks R, Toniolo P, Akhmedkhanov A, et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Canc Inst 2000; 92: 1592-600.
-
(2000)
J Natl Canc Inst
, vol.92
, pp. 1592-1600
-
-
Kaaks, R.1
Toniolo, P.2
Akhmedkhanov, A.3
-
50
-
-
0036892152
-
Utility of insulin-like growth factor-1 as a biomarker in epidemiologic studies
-
Borofsky ND, Vogelman JH, Krajcik RA, et al. Utility of insulin-like growth factor-1 as a biomarker in epidemiologic studies. Clin Chemistry 2002; 48: 2248-51.
-
(2002)
Clin Chemistry
, vol.48
, pp. 2248-2251
-
-
Borofsky, N.D.1
Vogelman, J.H.2
Krajcik, R.A.3
|